Bioxytran, Inc. (BIXT)

Bioxytran Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.01	0.03	0.3	0.07	0.04
Cash & Short-Term Investments	0.01	0.03	0.3	0.07	0.04
Cash Growth	-80.24%	-91.17%	308.25%	73.57%	-75.42%
Prepaid Expenses	-	-	-	-	0.27
Total Current Assets	0.01	0.03	0.3	0.07	0.32
Other Intangible Assets	-	-	-	-	0.01
Long-Term Deferred Charges	0.13	0.11	0.08	0.05	-
Total Assets	0.14	0.14	0.37	0.12	0.33
Accounts Payable	0.15	0	0	-	0
Accrued Expenses	0.28	0.3	1.46	1.16	0.35
Short-Term Debt	1.09	1.93	2.17	2.12	1.61
Other Current Liabilities	0.41	1.01	0.04	-	0.31
Total Current Liabilities	1.93	3.24	3.66	3.28	2.27
Total Liabilities	1.93	3.24	3.66	3.28	2.27
Common Stock	0.09	0.14	0.12	0.11	0.1
Additional Paid-In Capital	17	13.09	8.39	5.88	1.8
Retained Earnings	-18.92	-15.7	-11.22	-8.75	-4.72
Comprehensive Income & Other	-	0.05	-	-	-
Total Common Equity	-1.84	-2.42	-2.7	-2.76	-2.83
Minority Interest	-	-0.68	-0.59	-0.4	0.89
Shareholders' Equity	-1.79	-3.1	-3.29	-3.16	-1.94
Total Liabilities & Equity	0.14	0.14	0.37	0.12	0.33
Total Debt	1.09	1.93	2.17	2.12	1.61
Net Cash (Debt)	-1.09	-1.9	-1.87	-2.05	-1.57
Net Cash Per Share	-0.01	-0.01	-0.02	-0.02	-0.02
Filing Date Shares Outstanding	88.88	166.49	123.5	110.84	100.75
Total Common Shares Outstanding	86.78	145.64	123.25	110.84	97.45
Working Capital	-1.93	-3.22	-3.37	-3.21	-1.95
Book Value Per Share	-0.02	-0.02	-0.02	-0.02	-0.03
Tangible Book Value	-1.84	-2.42	-2.7	-2.76	-2.84
Tangible Book Value Per Share	-0.02	-0.02	-0.02	-0.02	-0.03

Source: S&P Global Market Intelligence. Standard template. Financial Sources.